U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C17H15FN2O2
Molecular Weight 298.3116
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MEFUPARIB

SMILES

CNCC1=CC=C(C=C1)C2=CC3=CC(F)=CC(C(N)=O)=C3O2

InChI

InChIKey=ROBJKLPZIPNAMV-UHFFFAOYSA-N
InChI=1S/C17H15FN2O2/c1-20-9-10-2-4-11(5-3-10)15-7-12-6-13(18)8-14(17(19)21)16(12)22-15/h2-8,20H,9H2,1H3,(H2,19,21)

HIDE SMILES / InChI

Molecular Formula C17H15FN2O2
Molecular Weight 298.3116
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 17:03:42 UTC 2023
Edited
by admin
on Sat Dec 16 17:03:42 UTC 2023
Record UNII
9NN2OZ1YX4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MEFUPARIB
Common Name English
Mefuparib [WHO-DD]
Common Name English
5-FLUORO-2-(4-((METHYLAMINO)METHYL)PHENYL)-7-BENZOFURANCARBOXAMIDE
Systematic Name English
CVL-218 FREE BASE
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 926722
Created by admin on Sat Dec 16 17:03:42 UTC 2023 , Edited by admin on Sat Dec 16 17:03:42 UTC 2023
Code System Code Type Description
CHEBI
167905
Created by admin on Sat Dec 16 17:03:42 UTC 2023 , Edited by admin on Sat Dec 16 17:03:42 UTC 2023
PRIMARY
FDA UNII
9NN2OZ1YX4
Created by admin on Sat Dec 16 17:03:42 UTC 2023 , Edited by admin on Sat Dec 16 17:03:42 UTC 2023
PRIMARY
PUBCHEM
71488522
Created by admin on Sat Dec 16 17:03:42 UTC 2023 , Edited by admin on Sat Dec 16 17:03:42 UTC 2023
PRIMARY
CAS
1392502-82-7
Created by admin on Sat Dec 16 17:03:42 UTC 2023 , Edited by admin on Sat Dec 16 17:03:42 UTC 2023
PRIMARY
DRUG CENTRAL
5378
Created by admin on Sat Dec 16 17:03:42 UTC 2023 , Edited by admin on Sat Dec 16 17:03:42 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
The selective inhibition of MPH against PARPs analyzed by biotinylated NAD+ -based luminescence assays
IC50
TARGET -> INHIBITOR
The selective inhibition of MPH against PARPs analyzed by biotinylated NAD+ -based luminescence assays
IC50
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY